These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 27250825)

  • 81. Targeting the Relaxin Pathway for Liver Disease Treatment.
    Bennett RG
    Eur Med J Hepatol; 2018 May; 6(1):80-87. PubMed ID: 31360529
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Novel Anti-fibrotic Therapies.
    McVicker BL; Bennett RG
    Front Pharmacol; 2017; 8():318. PubMed ID: 28620300
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Relative roles of the epithelial and stromal tissue compartment(s) in mediating the actions of relaxin and estrogen on cell proliferation and apoptosis in the mouse lower reproductive tract.
    Yao L; Agoulnik AI; Cooke PS; Meling DD; Sherwood OD
    Ann N Y Acad Sci; 2009 Apr; 1160():121-9. PubMed ID: 19416172
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Serelaxin inhibits differentiation and fibrotic behaviors of cardiac fibroblasts by suppressing ALK-5/Smad2/3 signaling pathway.
    Wu XP; Wang HJ; Wang YL; Shen HR; Tan YZ
    Exp Cell Res; 2018 Jan; 362(1):17-27. PubMed ID: 28987540
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Strategies for anti-fibrotic therapies.
    Rosenbloom J; Mendoza FA; Jimenez SA
    Biochim Biophys Acta; 2013 Jul; 1832(7):1088-103. PubMed ID: 23266403
    [TBL] [Abstract][Full Text] [Related]  

  • 86. cAMP and Epac in the regulation of tissue fibrosis.
    Insel PA; Murray F; Yokoyama U; Romano S; Yun H; Brown L; Snead A; Lu D; Aroonsakool N
    Br J Pharmacol; 2012 May; 166(2):447-56. PubMed ID: 22233238
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The anti-fibrotic hormone relaxin is not reno-protective, despite being active, in an experimental model of type 1 diabetes.
    Wong SE; Samuel CS; Kelly DJ; Zhang Y; Becker GJ; Hewitson TD
    Protein Pept Lett; 2013 Sep; 20(9):1029-38. PubMed ID: 23343143
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats.
    Lekgabe ED; Kiriazis H; Zhao C; Xu Q; Moore XL; Su Y; Bathgate RA; Du XJ; Samuel CS
    Hypertension; 2005 Aug; 46(2):412-8. PubMed ID: 15967869
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Therapeutic targets of fibrosis: Translational advances and current challenges.
    De Blasio MJ; Ohlstein EH; Ritchie RH
    Br J Pharmacol; 2023 Nov; 180(22):2839-2845. PubMed ID: 37846458
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Anti-fibrotic mechanisms of exogenously-expanded mesenchymal stromal cells for fibrotic diseases.
    Rockel JS; Rabani R; Viswanathan S
    Semin Cell Dev Biol; 2020 May; 101():87-103. PubMed ID: 31757583
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Relaxin in hepatic fibrosis: What is known and where to head?
    Ezhilarasan D
    Biochimie; 2021 Aug; 187():144-151. PubMed ID: 34102254
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The Role of Relaxin in Normal and Abnormal Uterine Function During the Menstrual Cycle and Early Pregnancy.
    Marshall SA; Senadheera SN; Parry LJ; Girling JE
    Reprod Sci; 2017 Mar; 24(3):342-354. PubMed ID: 27365367
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Relaxin activates the MAP kinase pathway in human endometrial stromal cells.
    Zhang Q; Liu SH; Erikson M; Lewis M; Unemori E
    J Cell Biochem; 2002; 85(3):536-44. PubMed ID: 11967993
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Improved chemical synthesis and demonstration of the relaxin receptor binding affinity and biological activity of mouse relaxin.
    Samuel CS; Lin F; Hossain MA; Zhao C; Ferraro T; Bathgate RA; Tregear GW; Wade JD
    Biochemistry; 2007 May; 46(18):5374-81. PubMed ID: 17425335
    [TBL] [Abstract][Full Text] [Related]  

  • 95.
    Ding C; Wang B; Lai XF; Guo Y; Tesch G; Ding X; Zheng J; Tian P; Ricardo S; Shen HH; Xue W
    Mater Today Bio; 2023 Aug; 21():100716. PubMed ID: 37545557
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The use of relaxin improves healing in injured muscle.
    Li Y; Negishi S; Sakamoto M; Usas A; Huard J
    Ann N Y Acad Sci; 2005 May; 1041():395-7. PubMed ID: 15956737
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Human relaxin decreases collagen accumulation in vivo in two rodent models of fibrosis.
    Unemori EN; Beck LS; Lee WP; Xu Y; Siegel M; Keller G; Liggitt HD; Bauer EA; Amento EP
    J Invest Dermatol; 1993 Sep; 101(3):280-5. PubMed ID: 8370965
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Simultaneously Targeting Myofibroblast Contractility and Extracellular Matrix Cross-Linking as a Therapeutic Concept in Airway Fibrosis.
    Lin YC; Sung YK; Jiang X; Peters-Golden M; Nicolls MR
    Am J Transplant; 2017 May; 17(5):1229-1241. PubMed ID: 27804215
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The pregnancy hormone relaxin binds to and activates the human glucocorticoid receptor.
    Dschietzig T; Bartsch C; Greinwald M; Baumann G; Stangl K
    Ann N Y Acad Sci; 2005 May; 1041():256-71. PubMed ID: 15956716
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Drugs of the future: the hormone relaxin.
    Samuel CS; Hewitson TD; Unemori EN; Tang ML
    Cell Mol Life Sci; 2007 Jun; 64(12):1539-57. PubMed ID: 17458501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.